BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28735489)

  • 1. A Zebrafish Model for Evaluating the Function of Human Leukemic Gene IDH1 and Its Mutation.
    Ma ACH; Shi X; He BL; Guo Y; Leung AYH
    Methods Mol Biol; 2017; 1633():193-218. PubMed ID: 28735489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.
    Shi X; He BL; Ma AC; Guo Y; Chi Y; Man CH; Zhang W; Zhang Y; Wen Z; Cheng T; Leung AY
    Blood; 2015 May; 125(19):2974-84. PubMed ID: 25778530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish provide ID(H)eas on targeting leukemia.
    Trompouki E
    Blood; 2015 May; 125(19):2880-2. PubMed ID: 25953976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
    Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
    Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics.
    Sasaki M; Knobbe CB; Munger JC; Lind EF; Brenner D; Brüstle A; Harris IS; Holmes R; Wakeham A; Haight J; You-Ten A; Li WY; Schalm S; Su SM; Virtanen C; Reifenberger G; Ohashi PS; Barber DL; Figueroa ME; Melnick A; Zúñiga-Pflücker JC; Mak TW
    Nature; 2012 Aug; 488(7413):656-9. PubMed ID: 22763442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IDH1 R132H mutation in acute myeloid leukemia by mutation-specific immunohistochemistry.
    Byers R; Hornick JL; Tholouli E; Kutok J; Rodig SJ
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):37-40. PubMed ID: 22172803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML.
    Payne EM; Bolli N; Rhodes J; Abdel-Wahab OI; Levine R; Hedvat CV; Stone R; Khanna-Gupta A; Sun H; Kanki JP; Gazda HT; Beggs AH; Cotter FE; Look AT
    Blood; 2011 Jul; 118(4):903-15. PubMed ID: 21653321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fishing the targets of myeloid malignancies in the era of next generation sequencing.
    Shi X; He BL; Ma AC; Leung AY
    Blood Rev; 2016 Mar; 30(2):119-30. PubMed ID: 26443083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance].
    Shang Z; Wang D; Xiao M; Geng Z; Wang HX; Wang J; Xu YL; Li TJ; Zhou JF; Li CR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1307-11. PubMed ID: 23257422
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Mazzola M; Deflorian G; Pezzotta A; Ferrari L; Fazio G; Bresciani E; Saitta C; Ferrari L; Fumagalli M; Parma M; Marasca F; Bodega B; Riva P; Cotelli F; Biondi A; Marozzi A; Cazzaniga G; Pistocchi A
    Haematologica; 2019 Jul; 104(7):1332-1341. PubMed ID: 30630974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDH mutations in glioma and acute myeloid leukemia.
    Dang L; Jin S; Su SM
    Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of FLT3/TKD and IDH1 Mutations in Pakistani Acute Myeloid Leukemia Patients by Denaturing HPLC.
    Ali A; Gale RE; Shakoori AR
    J Cell Biochem; 2017 May; 118(5):1174-1181. PubMed ID: 27735988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions.
    Upadhyay VA; Brunner AM; Fathi AT
    Pharmacol Ther; 2017 Sep; 177():123-128. PubMed ID: 28315358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
    Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
    Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice.
    Hao Z; Cairns RA; Inoue S; Li WY; Sheng Y; Lemonnier F; Wakeham A; Snow BE; Dominguez-Brauer C; Ye J; Larsen DM; Straley KS; Tobin ER; Narayanaswamy R; Gaulard P; Mak TW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1387-92. PubMed ID: 26787889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease.
    Deveau AP; Forrester AM; Coombs AJ; Wagner GS; Grabher C; Chute IC; Léger D; Mingay M; Alexe G; Rajan V; Liwski R; Hirst M; Steigmaier K; Lewis SM; Look AT; Berman JN
    Leukemia; 2015 Oct; 29(10):2086-97. PubMed ID: 26017032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway.
    Cai Y; Wang J; Jin D; Liu Q; Chen X; Pan L; Li Y; Wang X; Qian F; Wang J; Zhong TP; Wang S
    Cancer Sci; 2021 Sep; 112(9):3884-3894. PubMed ID: 34077586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
    Gupta C; Kaulfuss S; Görlich K; Othman B; Chaturvedi A; Heuser M
    Ann Hematol; 2020 Jun; 99(6):1415-1417. PubMed ID: 32296913
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K/AKT/mTOR signaling?
    Hauge M; Bruserud Ø; Hatfield KJ
    Eur J Haematol; 2016 Mar; 96(3):211-21. PubMed ID: 26465810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.